As Epizyme (EPZM) Valuation Rose, Foresite Capital Management Ii Boosted by $1.11 Million Its Holding; Phoenix Investment Adviser Lifted Its Autoliv (ALV) Position by $369,000; Valuation Declined

February 15, 2018 - By Dolores Ford

Phoenix Investment Adviser Llc increased its stake in Autoliv Inc (ALV) by 60% based on its latest 2017Q3 regulatory filing with the SEC. Phoenix Investment Adviser Llc bought 3,000 shares as the company’s stock declined 0.90% while stock markets rallied. The hedge fund held 8,000 shares of the capital goods company at the end of 2017Q3, valued at $989,000, up from 5,000 at the end of the previous reported quarter. Phoenix Investment Adviser Llc who had been investing in Autoliv Inc for a number of months, seems to be bullish on the $12.67B market cap company. The stock increased 0.37% or $0.53 during the last trading session, reaching $145.68. About 244,853 shares traded. Autoliv, Inc. (NYSE:ALV) has declined 12.54% since February 15, 2017 and is downtrending. It has underperformed by 29.24% the S&P500.

Jim Tanenbaum increased its stake in Epizyme Inc. (EPZM) by 3.93% based on its latest 2017Q3 regulatory filing with the SEC. Foresite Capital Management Ii Llc bought 58,368 shares as the company’s stock rose 39.84% with the market. The hedge fund run by Jim Tanenbaum held 1.54 million shares of the health care company at the end of 2017Q3, valued at $29.40 million, up from 1.48M at the end of the previous reported quarter. Foresite Capital Management Ii Llc who had been investing in Epizyme Inc. for a number of months, seems to be bullish on the $1.32 billion market cap company. The stock increased 0.26% or $0.05 during the last trading session, reaching $19.05. About 271,178 shares traded. Epizyme, Inc. (NASDAQ:EPZM) has risen 91.85% since February 15, 2017 and is uptrending. It has outperformed by 75.15% the S&P500.

Since August 24, 2017, it had 1 buying transaction, and 4 sales for $1.11 million activity. The insider MOTT DAVID M bought $3.05 million. 72,264 shares valued at $1.20M were sold by Ros Matthew on Monday, February 5.

Among 13 analysts covering Epizyme (NASDAQ:EPZM), 12 have Buy rating, 0 Sell and 1 Hold. Therefore 92% are positive. Epizyme had 31 analyst reports since August 6, 2015 according to SRatingsIntel. On Tuesday, August 1 the stock rating was maintained by Oppenheimer with “Buy”. Oppenheimer maintained Epizyme, Inc. (NASDAQ:EPZM) on Monday, July 24 with “Buy” rating. Citigroup initiated the stock with “Buy” rating in Tuesday, April 5 report. The stock has “Buy” rating by Leerink Swann on Thursday, June 15. RBC Capital Markets maintained Epizyme, Inc. (NASDAQ:EPZM) on Monday, September 28 with “Outperform” rating. On Monday, June 12 the stock rating was maintained by RBC Capital Markets with “Buy”. The rating was maintained by RBC Capital Markets with “Buy” on Thursday, September 14. The stock of Epizyme, Inc. (NASDAQ:EPZM) has “Buy” rating given on Tuesday, August 25 by Zacks. The stock of Epizyme, Inc. (NASDAQ:EPZM) has “Buy” rating given on Tuesday, May 10 by Mizuho. As per Friday, August 4, the company rating was maintained by RBC Capital Markets.

Investors sentiment decreased to 1.46 in Q3 2017. Its down 0.47, from 1.93 in 2017Q2. It fall, as 15 investors sold EPZM shares while 22 reduced holdings. 13 funds opened positions while 41 raised stakes. 58.04 million shares or 22.28% more from 47.46 million shares in 2017Q2 were reported. Eventide Asset Management Ltd Liability Corporation holds 0.3% in Epizyme, Inc. (NASDAQ:EPZM) or 275,000 shares. Laurion Mngmt LP holds 0.02% or 237,859 shares in its portfolio. Rhumbline Advisers owns 50,620 shares. Point72 Asset Mngmt LP accumulated 0.08% or 923,400 shares. Principal Financial Gp owns 96,248 shares. 15,333 were accumulated by Jgp Gestao De Recursos Ltda. Rock Springs Cap Limited Partnership, Maryland-based fund reported 1.35 million shares. Schwab Charles Investment invested in 0% or 217,168 shares. Bluecrest Management accumulated 17,813 shares or 0.01% of the stock. Oracle Invest has 1.15% invested in Epizyme, Inc. (NASDAQ:EPZM) for 369,403 shares. Qs Ltd Limited Liability Company holds 0.01% or 92,668 shares in its portfolio. Foresite Capital Mgmt Ii Ltd Liability stated it has 1.54 million shares or 11.92% of all its holdings. Quantbot LP has 0% invested in Epizyme, Inc. (NASDAQ:EPZM) for 1,073 shares. Citigroup Inc, New York-based fund reported 36,411 shares. Moreover, Manufacturers Life Insurance Com The has 0% invested in Epizyme, Inc. (NASDAQ:EPZM) for 32,446 shares.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>